Neil Klompas
Director/Board Member presso LIMINAL BIOSCIENCES INC.
Patrimonio netto: 212 961 $ in data 29/02/2024
Profilo
Neil A.
Klompas is on the board of Liminal BioSciences, Inc., Ovensa, Inc. and Canadian Gene Cure Foundation and Member of The Chartered Professional Accountants of British Columbia.
In the past he held the position of President & Chief Operating Officer of Zymeworks, Inc. and Chief Operating Officer at Zymeworks BC, Inc. (a subsidiary of Zymeworks, Inc.), Manager-Mergers & Acquisitions Transactions at KPMG LLP and Audit Manager at KPMG LLP (Canada).
Neil A.
Klompas received an undergraduate degree from the University of British Columbia.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ZYMEWORKS INC.
0.03% | 11/10/2023 | 17 732 ( 0.03% ) | 212 961 $ | 29/02/2024 |
Posizioni attive di Neil Klompas
Società | Posizione | Inizio |
---|---|---|
LIMINAL BIOSCIENCES INC. | Director/Board Member | 01/05/2019 |
The Chartered Professional Accountants of British Columbia
The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Corporate Officer/Principal | - |
Canadian Gene Cure Foundation | Director/Board Member | - |
Ovensa, Inc.
Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Director/Board Member | 01/01/2017 |
Precedenti posizioni note di Neil Klompas
Società | Posizione | Fine |
---|---|---|
ZYMEWORKS INC. | President | 30/06/2023 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director of Finance/CFO | 24/02/2022 |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2007 |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of accounting, tax preparation, and advisory services. It also offers auditing, internal audit, regulatory and compliance, corporate recovery, and forensic accounting, and risk management services. The company was founded in 1869 and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | 01/01/2005 |
Formazione di Neil Klompas
University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LIMINAL BIOSCIENCES INC. | Health Technology |
ZYMEWORKS INC. | Health Technology |
Aziende private | 6 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of accounting, tax preparation, and advisory services. It also offers auditing, internal audit, regulatory and compliance, corporate recovery, and forensic accounting, and risk management services. The company was founded in 1869 and is headquartered in Toronto, Canada. | Commercial Services |
The Chartered Professional Accountants of British Columbia
The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Commercial Services |
Ovensa, Inc.
Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Technology Services |
Canadian Gene Cure Foundation |